EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieValidierungsstudie

18F-FDG PET/CT-based radiomics model for predicting the degree of pathological differentiation in non-small cell lung cancer: a multicentre study

F Liu, Z Xiang, Q Li, X Fang, J Zhou, X Yang, H Lin, Q Yang

Clinical Radiology · 2024

DOI: 10.1016/j.crad.2023.09.017 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Radiology, 2024. Verfasst von F Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: University of South China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: To explore the value of 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) positron-emission tomography (PET)/computed tomography (CT)-based radiomics model for predicting the degree of pathological differentiation in non-small-cell lung cancer (NSCLC). MATERIALS AND METHODS: Clinical characteristics of 182 NSCLC patients from four centres were collected, and radiomics features were extracted from 18F-FDG PET/CT images. Three logistic regression prediction models were established: clinical model; radiomics model; and nomogram combining radiomics signatures and clinical features. The predictive ability of the models was assessed using receiver operating characteristics curve analysis. RESULTS: Patients from centre 1 were assigned randomly to the training and internal validation cohorts (7:3 ratio); patients from centres 2-4 served as the external validation cohort. The area under the curve (AUC) values for the clinical model in the training, internal validation, and external validation cohort were 0.74 (95% confidence interval [CI] = 0.64-0.84), 0.64 (95% CI = 0.46-0.81), and 0.74 (95% CI = 0.60-0.88), respectively. In the training (AUC: 0.84 [95% CI = 0.77-0.92]), internal validation (AUC: 0.81 [95% CI = 0.67-0.95]), and external validation cohorts (AUC: 0.74 [95% CI = 0.58-0.89]), the radiomics model showed good predictive ability for differentiation. Compared to the clinical and radiomics models, the nomogram has relatively better diagnostic performance, and the AUC values for nomogram in the training, internal validation, and external validation cohort were 0.86 (95% CI = 0.78-0.93), 0.83 (95% CI = 0.70-0.96), and 0.77 (95% CI = 0.62-0.92), respectively. CONCLUSIONS: The 18F-FDG PET/CT-based radiomics model showed good ability for predicting the degree of differentiation of NSCLC. The nomogram combining the radiomics signature and clinical features has relatively better diagnostic performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansFluorodeoxyglucose F18NomogramsPositron Emission Tomography Computed TomographyRadiomicsRetrospective Studies

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Radiology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.
  • Department of Radiology, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China. Electronic address: fangxiangjun118@163.com.
  • The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, China.
  • Sichuan Science City Hospital, Mianyang, Sichuan 621000, China.
  • Department of Pharmaceutical Diagnosis, GE Healthcare, Changsha 410005, China.
  • Center for Molecular Imaging Probe, Hunan Province Key Laboratory of Tumour Cellular and Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.…

Förderung

  • University of South China

Zitieren

APA

Liu, F., Xiang, Z., Li, Q., Fang, X., Zhou, J., Yang, X., Lin, H., & Yang, Q. (2024). 18F-FDG PET/CT-based radiomics model for predicting the degree of pathological differentiation in non-small cell lung cancer: a multicentre study. Clinical Radiology. https://doi.org/10.1016/j.crad.2023.09.017

Vancouver

Liu F, Xiang Z, Li Q, Fang X, Zhou J, Yang X, et al. 18F-FDG PET/CT-based radiomics model for predicting the degree of pathological differentiation in non-small cell lung cancer: a multicentre study. Clinical Radiology. 2024. doi:10.1016/j.crad.2023.09.017

BibTeX
@article{Liu2024,
  author = {Liu, F and Xiang, Z and Li, Q and Fang, X and Zhou, J and Yang, X and Lin, H and Yang, Q},
  title = {18F-FDG PET/CT-based radiomics model for predicting the degree of pathological differentiation in non-small cell lung cancer: a multicentre study},
  journal = {Clinical Radiology},
  year = {2024},
  doi = {10.1016/j.crad.2023.09.017}
}
Kostenlos starten →